Welcome to LookChem.com Sign In|Join Free
  • or
IroMycin A is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

213137-53-2

Post Buying Request

213137-53-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

213137-53-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 213137-53-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,3,1,3 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 213137-53:
(8*2)+(7*1)+(6*3)+(5*1)+(4*3)+(3*7)+(2*5)+(1*3)=92
92 % 10 = 2
So 213137-53-2 is a valid CAS Registry Number.

213137-53-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-hydroxy-6-[(E,E)-3,7-dimethylocta-2,5-dienyl]-3-methyl-5-propyl-1H-pyridin-2-one

1.2 Other means of identification

Product number -
Other names IROMYCIN A

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:213137-53-2 SDS

213137-53-2Downstream Products

213137-53-2Relevant academic research and scientific papers

Iromycins: A new family of pyridone metabolites from Streptomyces sp. II. Convergent total synthesis

Shojaei, Heydar,Li-Boehmer, Zhen,Von Zezschwitz, Paultheo

, p. 5091 - 5097 (2007)

(Chemical Equation Presented) The total synthesis of iromycin A (1a), a microbial metabolite combining a novel structure with an interesting biological activity as a NO synthase inhibitor, was accomplished using a flexible and highly convergent approach. Thus, the ring fragment was prepared as 6-bromomethylpyrone 27 by acylation of the respective β-ketoester 13 and subsequent lactonization of the thus-obtained β,δ-diketoester 11, followed by bromination of the 6-methyl group. In addition, the unsaturated side chain was efficiently prepared as terminal alkyne 34 which was then carboaluminated to furnish the alkenyldimethylalane 35. The assembly of these two fragments was thoroughly studied using nickel, palladium, and copper catalysts yet only succeeded in the absence of any transition metal after formation of the respective lithium alkenyltrialkylalanate. Treatment of the coupled product 41 with liquid ammonia then completed the total synthesis which furnished an 18% overall yield over the nine steps of the longest linear sequence.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 213137-53-2